1. Home
  2. CNTX vs UFI Comparison

CNTX vs UFI Comparison

Compare CNTX & UFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • UFI
  • Stock Information
  • Founded
  • CNTX 2015
  • UFI 1969
  • Country
  • CNTX United States
  • UFI United States
  • Employees
  • CNTX N/A
  • UFI N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • UFI Textiles
  • Sector
  • CNTX Health Care
  • UFI Consumer Discretionary
  • Exchange
  • CNTX Nasdaq
  • UFI Nasdaq
  • Market Cap
  • CNTX 75.6M
  • UFI 84.6M
  • IPO Year
  • CNTX 2021
  • UFI N/A
  • Fundamental
  • Price
  • CNTX $1.26
  • UFI $4.39
  • Analyst Decision
  • CNTX Strong Buy
  • UFI
  • Analyst Count
  • CNTX 7
  • UFI 0
  • Target Price
  • CNTX $5.20
  • UFI N/A
  • AVG Volume (30 Days)
  • CNTX 500.2K
  • UFI 50.5K
  • Earning Date
  • CNTX 11-10-2025
  • UFI 10-29-2025
  • Dividend Yield
  • CNTX N/A
  • UFI N/A
  • EPS Growth
  • CNTX N/A
  • UFI N/A
  • EPS
  • CNTX N/A
  • UFI N/A
  • Revenue
  • CNTX N/A
  • UFI $571,344,000.00
  • Revenue This Year
  • CNTX N/A
  • UFI $9.98
  • Revenue Next Year
  • CNTX N/A
  • UFI $5.75
  • P/E Ratio
  • CNTX N/A
  • UFI N/A
  • Revenue Growth
  • CNTX N/A
  • UFI N/A
  • 52 Week Low
  • CNTX $0.49
  • UFI $4.25
  • 52 Week High
  • CNTX $2.46
  • UFI $7.15
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 56.22
  • UFI 39.89
  • Support Level
  • CNTX $1.19
  • UFI $4.32
  • Resistance Level
  • CNTX $1.50
  • UFI $4.45
  • Average True Range (ATR)
  • CNTX 0.15
  • UFI 0.15
  • MACD
  • CNTX -0.02
  • UFI -0.03
  • Stochastic Oscillator
  • CNTX 39.78
  • UFI 19.15

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

Share on Social Networks: